Noveris Health Sciences Inc. is trading at $1.69 (+5.62%) as the stock rebounds, reflecting renewed investor optimism. - The uplift appears linked to ongoing strategic developments, including a focus on commercialization and intellectual property monetization. - The company has also recently appointed a Chair to its Advisory Board and a Strategic Advisor, further signaling its growth initiatives.